News, infos and good to know WKN: A2QQ2E ISIN: US45256X1037 Kürzel: IBRX Forum: Aktien User: Lirumlarum1

Der Milliardär Soon-Shiong eröffnet eine 1-Milliarden-Dosis-Impfstofffabrik in Kapstadt : https://finance.yahoo.com/news/billionaire-soon-shiong-launches-1-100115432.html

Ergebnisse Phase 2 Bauchspeicheldrüsenkrebs: https://immunitybio.com/immunitybio-announces-results-of-phase-2-metastatic-pancreatic-cancer-trial-at-asco-gi-with-median-overall-survival-of-6-3-months-in-patients-with-third-line-disease-more-than-doubling-historical-sur/

Covid-19 manufacturing roundup: NY biotech primed to become ImmunityBio's drug substance goldmine; Illinois set to meet demand for at-home tests https://endpts.com/covid-19-manufacturing-roundup-ny-biotech-primed-to-become-immunitybios-drug-substance-goldmine-illinois-set-to-meet-demand-for-at-home-tests/

Over 400,000 square foot, state-of-the-art, finish-fill and lyophilization facility enables one billion doses of RNA and adjuvant vaccine production Newly constructed Current Good Manufacturing Practices (cGMP) facility with clean rooms will expedite capabilities for large-scale manufacture of self-amplifying RNA and second-generation DNA COVID-19 vaccine platforms, as well as immunotherapy product candidates ImmunityBio’s cGMP cell therapy, fusion protein, and vaccine biological manufacturing plants now span the globe enabling vertically integrated, commercial-scale manufacturing capacity

ImmunityBio Expands Manufacturing Capacity with State-of-the-Art Manufacturing Plant in New York for Global Pandemic Response and Preparedness https://ir.immunitybio.com/news-releases/news-release-details/immunitybio-expands-manufacturing-capacity-state-art?field_nir_news_date_value[min]=

Soon-Shiong Pours Another $300M Into ImmunityBio https://labusinessjournal.com/news/2022/jan/10/soon-shiong-pours-another-300m-immunitybio/

Amyris and ImmunityBio surge after announcing completion of JV https://seekingalpha.com/amp/news/3784653-amyris-and-immunitybio-surge-after-announcing-completion-of-jv

ImmunityBio Awarded Seminal Patent on Natural Killer Cells https://ir.immunitybio.com/news-releases/news-release-details/immunitybio-awarded-seminal-patent-natural-killer-cells?field_nir_news_date_value[min]=

Amyris and Immunitybio Complete Joint Venture for Next Generation Covid-19 RNA Vaccine https://ir.immunitybio.com/news-releases/news-release-details/amyris-and-immunitybio-complete-joint-venture-next-generation?field_nir_news_date_value[min]=

Dr. Pat Soon-Shiong @DrPatSoonShiong 19 hours ago: The old style Newsaper still lives on..for some. WSJ article on New Year’s Eve now 2 years since COVID ..”while antibodies block, T cells attack and kill cells that are infected”. We have said this over and over and over .. the next generation vaccine to stop transmission ⁦

ImmunityBio, Inc. @ImmunityBio 1 hour ago: Important findings as we start the New Year: A pair of separate studies—from the Netherlands and South Africa—have found that T cells mobilized by vaccination reduce the severity of the disease. https://www.wsj.com/articles/the-t-cell-covid-cavalry-antibodies-vaccines-omicron-11640906490

Harry Reid ist verstorben. https://amp.cnn.com/cnn/2021/12/28/politics/harry-reid-dies/index.html

ImmunityBio pares gains following aldoxorubicin data in cancer https://seekingalpha.com/amp/news/3783723-immunitybio-pares-gains-following-aldoxorubicin-data-in-cancer